BESSEMER GROUP INC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 195 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.4%.

Quarter-by-quarter ownership
BESSEMER GROUP INC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q1 2022$6,000
+20.0%
1600.0%0.00%
Q4 2021$5,000
+25.0%
1600.0%0.00%
Q3 2021$4,000
-33.3%
1600.0%0.00%
Q2 2021$6,000
-14.3%
1600.0%0.00%
Q1 2021$7,000
-68.2%
160
-68.0%
0.00%
Q4 2020$22,000
-38.9%
500
-23.1%
0.00%
Q3 2020$36,000
-42.9%
650
-35.0%
0.00%
Q2 2020$63,000
-95.9%
1,000
-98.0%
0.00%
-100.0%
Q3 2017$1,553,000
+13.5%
50,0090.0%0.01%0.0%
Q2 2017$1,368,000
+308.4%
50,009
+115.9%
0.01%
+200.0%
Q4 2016$335,00023,1600.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q2 2022
NameSharesValueWeighting ↓
Fernwood Investment Management, LLC 327,905$17,248,0009.44%
Asymmetry Capital Management, L.P. 314,217$16,528,0008.95%
Perceptive Advisors 5,775,726$303,803,0006.97%
NEXTHERA CAPITAL LP 142,305$7,485,0006.23%
Grace Capital 244,914$12,882,0006.14%
Broadfin Capital, LLC 316,619$16,654,0003.62%
Ghost Tree Capital, LLC 300,000$15,780,0003.27%
ArchPoint Investors 156,635$8,239,0002.61%
STANSBERRY ASSET MANAGEMENT, LLC 114,562$6,026,0002.37%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 13,928$733,0002.07%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders